$STAA
STAAR Surgical Co Stock $staa

$staa Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000114420417024211 Filed on May 03, 2017

Income Statement

Concept	2017 Q1	2016 Q2
Revenue	$20.35M	$19.27M
YoY Change	-2.44%	2.18%
Cost Of Revenue	$5.773M	$6.276M
YoY Change	-6.74%	5.3%
Gross Profit	$14.58M	$12.99M
YoY Change	-0.59%	0.73%
Gross Profit Margin	71.63%	67.43%
Selling, General & Admin	$16.66M	$16.14M
YoY Change	54.7%	49.72%
% of Gross Profit	114.3%	124.22%
Research & Development	$4.783M	$6.906M
YoY Change	20.78%	92.91%
% of Gross Profit	32.81%	53.15%
Depreciation & Amortization	$756.0K	$591.0K
YoY Change	8.0%	18.91%
% of Gross Profit	5.19%	4.55%
Operating Expenses	$21.44M	$23.05M
YoY Change	45.58%	59.93%
Operating Profit	-$2.095M	-$10.05M
YoY Change	3074.24%	565.32%
Interest Expense	-$28.00K	$28.00K
YoY Change	-90.34%	-103.01%
% of Operating Profit
Other Income/Expense, Net	$22.00K	$408.0K
YoY Change	-93.13%	482.86%
Pretax Income	-$2.062M	-$9.650M
YoY Change	6773.33%	307.17%
Income Tax	$141.0K	-$1.600M
% Of Pretax Income
Net Earnings	-$2.203M	-$8.041M
YoY Change	161.64%	243.63%
Net Earnings / Revenue	-10.83%	-41.73%
Basic Earnings Per Share	-$0.05
Diluted Earnings Per Share	-$0.05	-$201.1K
COMMON SHARES
Basic Shares Outstanding	40.75M shares	40.19M shares
Diluted Shares Outstanding	40.75M shares

Balance Sheet

Concept	2017 Q1	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.50M	$9.000M
YoY Change	0.75%	-16.67%
Cash & Equivalents	$13.50M	$8.968M
Short-Term Investments
Other Short-Term Assets	$666.0K	$216.0K
YoY Change	41.7%	-40.66%
Inventory	$14.60M	$16.00M
Prepaid Expenses	$1.567M	$2.636M
Receivables	$15.60M	$16.20M
Other Receivables	$1.700M	$1.200M
Total Short-Term Assets	$49.05M	$46.20M
YoY Change	-0.05%	7.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.11M	$11.00M
YoY Change	20.0%	11.11%
Goodwill	$1.786M
YoY Change	0.0%
Intangibles	$439.0K
YoY Change	-34.08%
Long-Term Investments
YoY Change
Other Assets	$948.0K	$2.200M
YoY Change	53.65%	69.23%
Total Long-Term Assets	$16.39M	$15.70M
YoY Change	18.09%	13.77%
TOTAL ASSETS
Total Short-Term Assets	$49.05M	$46.20M
Total Long-Term Assets	$16.39M	$15.70M
Total Assets	$65.44M	$61.90M
YoY Change	3.95%	8.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.602M	$6.900M
YoY Change	13.62%	40.82%
Accrued Expenses	$6.100M	$4.200M
YoY Change	19.61%	13.51%
Deferred Revenue
YoY Change
Short-Term Debt	$4.500M	$4.500M
YoY Change	7.14%	7.14%
Long-Term Debt Due	$1.300M	$400.0K
YoY Change	225.0%	33.33%
Total Short-Term Liabilities	$21.80M	$18.00M
YoY Change	21.85%	20.0%
LONG-TERM LIABILITIES
Long-Term Debt	$1.400M	$100.0K
YoY Change	600.0%	-75.0%
Other Long-Term Liabilities	$4.400M	$4.300M
YoY Change	7.32%	34.38%
Total Long-Term Liabilities	$5.800M	$4.400M
YoY Change	34.88%	22.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.80M	$18.00M
Total Long-Term Liabilities	$5.800M	$4.400M
Total Liabilities	$28.48M	$23.55M
YoY Change	18.12%	14.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$161.3M	-$155.0M
YoY Change	9.75%
Common Stock	$199.0M	$194.4M
YoY Change	6.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.96M	$38.33M
YoY Change
Total Liabilities & Shareholders Equity	$65.44M	$61.88M
YoY Change	3.95%	8.94%

Cashflow Statement

Concept	2017 Q1	2016 Q2
OPERATING ACTIVITIES
Net Income	-$2.203M	-$8.041M
YoY Change	161.64%	243.63%
Depreciation, Depletion And Amortization	$756.0K	$591.0K
YoY Change	8.0%	18.91%
Cash From Operating Activities	-$692.0K	-$2.980M
YoY Change	-62.39%	34.84%
INVESTING ACTIVITIES
Capital Expenditures	$246.0K	$1.006M
YoY Change	-131.95%	206.71%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$246.0K	-$1.010M
YoY Change	-67.63%	206.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$79.00K	-700.0K
YoY Change	-231.67%	-325.81%
NET CHANGE
Cash From Operating Activities	-$692.0K	-2.980M
Cash From Investing Activities	-$246.0K	-1.010M
Cash From Financing Activities	$79.00K	-700.0K
Net Change In Cash	-$499.0K	-4.690M
YoY Change	-81.24%	110.31%
FREE CASH FLOW
Cash From Operating Activities	-$692.0K	-$2.980M
Capital Expenditures	$246.0K	$1.006M
Free Cash Flow	-$938.0K	-$3.986M
YoY Change	-12.34%	57.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	49517000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	49047000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11790000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12114000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	473000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	439000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1786000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	1786000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	772000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	948000	USD
CY2016Q4	us-gaap	Assets Assets	65443000	USD
CY2017Q1	us-gaap	Assets Assets	65439000	USD
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4283000	USD
CY2017Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4474000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8311000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7602000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1198000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1294000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7275000	USD
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8425000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21067000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21795000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1339000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1425000	USD
CY2016Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	195000	USD
CY2017Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	204000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	27538000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	28477000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	407000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	409000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	197657000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	198596000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1050000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-731000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159109000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161312000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	37905000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	36962000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65443000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65439000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	58000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	59000	USD
CY2017Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	4121000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	19269000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	20350000	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5773000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6276000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5359000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8465000	USD
CY2017Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6530000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7675000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4783000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6906000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2095000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	28000	USD
CY2017Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-86000	USD
CY2016Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	458000	USD
CY2017Q1	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	131000	USD
CY2016Q2	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	22000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-44000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	33000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	408000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	141000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1604000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-2203000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8041000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2062000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.2
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40749000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39983000	shares
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	732000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	448000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	520000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	319000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7521000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1884000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	591000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	756000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1639000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7000	USD
CY2016Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	118000	USD
CY2017Q1	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	66000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7458000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	510000	USD
CY2016Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-22000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	232000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	317000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-624000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-564000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-402000	USD
CY2016Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	912000	USD
CY2017Q1	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	1083000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-435000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1157000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-398000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1114000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2979000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-625000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1006000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	313000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1006000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-313000	USD
CY2016Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	92000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	301000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-696000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	79000	USD
CY2016Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	247000	USD
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	360000	USD
CY2016Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13521000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	14118000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	9087000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13619000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-499000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4434000	USD
CY2017Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	217000	USD
CY2016Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	611000	USD
CY2017Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67000	USD
CY2016Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2017Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2090000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2264000	USD
CY2017Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1744000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1924000	USD
CY2017Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13711000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14268000	USD
CY2017Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2899000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3631000	USD
CY2017Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1567000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1003000	USD
CY2017Q1	staa	Consumption Tax Receivable ConsumptionTaxReceivable	567000	USD
CY2016Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	668000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	666000	USD
CY2017Q1	us-gaap	Prepaid Insurance PrepaidInsurance	972000	USD
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	935000	USD
CY2016Q4	staa	Consumption Tax Receivable ConsumptionTaxReceivable	573000	USD
CY2016Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	501000	USD
CY2017Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	722000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1568000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1507000	USD
CY2017Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	151000	USD
CY2016Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	424000	USD
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Trading Symbol TradingSymbol	STAA
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	799000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1095000	USD
CY2016Q2	staa	Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStock	0	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2846000	shares
CY2017Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60	pure
CY2017Q1	staa	Sales Exceed Percentage SalesExceedPercentage	0.1	pure
CY2017Q1	staa	Compensation Cost Capitalised CompensationCostCapitalised	-52000	USD
CY2016Q2	staa	Compensation Cost Capitalised CompensationCostCapitalised	-152000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7610000	USD
CY2017Q1	staa	Estimated Forfeiture Rate EstimatedForfeitureRate	0.054	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.57	pure
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.57	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0196	pure
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0140	pure
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M1D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M25D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3502000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	739000	shares
CY2017Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	116000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4118000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2842000	shares
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	STAAR SURGICAL CO
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000718937
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40932317	shares
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2295000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2056000	USD
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40889000	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40889000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40732000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40732000	shares
CY2017Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-14000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-11000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-20000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-27000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	135000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	228000	USD
CY2017Q1	us-gaap	Inventory Gross InventoryGross	17545000	USD
CY2016Q4	us-gaap	Inventory Gross InventoryGross	18456000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Amortization Of Net Transition Asset Obligation DefinedBenefitPlanAmortizationOfNetTransitionAssetObligation	3000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Amortization Of Net Transition Asset Obligation DefinedBenefitPlanAmortizationOfNetTransitionAssetObligation	3000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-17000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-24000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	138000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	173000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37916000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37011000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	127000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	151000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	14000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	17000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	23000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	22000	USD
CY2017Q1	us-gaap	Entity Wide Disclosure On Geographic Areas Description Of Revenue From External Customers EntityWideDisclosureOnGeographicAreasDescriptionOfRevenueFromExternalCustomers	The Company markets and sells its products in over 60 countries and conducts its manufacturing in the United States. Other than Japan, China, the United States, and Korea, the Company does not conduct business in any country in which its sales exceed 10% of consolidated net sales.
CY2017Q1	staa	Segment Sales To Consolidated Sales Percentage SegmentSalesToConsolidatedSalesPercentage	1	pure
CY2016Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	500000000	JPY
CY2017Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1000000	CHF
CY2017Q1	staa	Percentage Of Commission On Outstanding Notes Payable PercentageOfCommissionOnOutstandingNotesPayable	0.0025	pure
CY2017Q1	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	1958311	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1105000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1105000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	874000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	881000	USD
CY2016Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	119000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1600000	USD
CY2017Q1	staa	Proceeds From Vested Restricted Stock And Exercise Of Stock Options ProceedsFromVestedRestrictedStockAndExerciseOfStockOptions	597000	USD
CY2016Q2	staa	Proceeds From Vested Restricted Stock And Exercise Of Stock Options ProceedsFromVestedRestrictedStockAndExerciseOfStockOptions	7000	USD
CY2017Q1	staa	Interest Rate Increase In Case Of Default InterestRateIncreaseInCaseOfDefault	0.14	pure
CY2017Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	500000000	JPY
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8968000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13402000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	119000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	119000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	119000	USD
CY2017Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	350000	USD
CY2016Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	USD

Files In Submission

Name	View Source	Status
0001144204-17-024211-index-headers.html	Edgar Link	pending
0001144204-17-024211-index.html	Edgar Link	pending
0001144204-17-024211.txt	Edgar Link	pending
0001144204-17-024211-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
staa-20170331.xml	Edgar Link	completed
staa-20170331.xsd	Edgar Link	pending
staa-20170331_cal.xml	Edgar Link	unprocessable
staa-20170331_def.xml	Edgar Link	unprocessable
staa-20170331_lab.xml	Edgar Link	unprocessable
staa-20170331_pre.xml	Edgar Link	unprocessable
v465041_10q.htm	Edgar Link	pending
v465041_ex31-1.htm	Edgar Link	pending
v465041_ex31-2.htm	Edgar Link	pending
v465041_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STAA
STAAR Surgical Co Stock $staa

2017 Q1 Form 10-Q Financial Statement

#000114420417024211 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA STAAR Surgical Co Stock $staa

2017 Q1 Form 10-Q Financial Statement

#000114420417024211 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA
STAAR Surgical Co Stock $staa